drugset / Trial / NCT05947578
The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.
NaSequentialOpen-labelTreatment
Summary
A Phase 1, Open-Label, Prospective, Dose-finding Clinical Trial for Evaluation of Safety and Tolerability of Intramuscular Injections of CLZ-2002 for the Treatment of Subjects with Charcot-Marie-Tooth type 1(CMT 1)
Timeline
- Start
- 2023-06-19
- Primary completion
- 2024-08-09
- Completion
- 2024-08-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CLZ-2002 | Unknown | 6e+06 cells | Intramuscular |
| Subject | CLZ-2002 | Unknown | 1.2e+07 cells | Intramuscular |
| Subject | CLZ-2002 | Unknown | 2.4e+07 cells | Intramuscular |